ANP no AVA: order AOD-9604 5mg

What Is AOD-9604 5mg Research Peptide?

AOD-9604 5mg Research Peptide is a synthetic peptide research material supplied by Axion Peptide Lab for controlled laboratory, analytical, and scientific investigations.

AOD-9604 is a 16-amino-acid synthetic peptide derived from the C-terminal region of human growth hormone (hGH). It corresponds to hGH residues 177–191 with an additional tyrosine residue at the N-terminus.

The compound has historically been investigated in metabolic research, particularly in experimental studies examining lipid metabolism, adipose-tissue biology, peptide stability, and biochemical signaling.

The 5mg designation represents the nominal quantity of research material supplied. It is not a recommended dose.

For Research Use Only – Not for human or veterinary consumption or administration.

What Is AOD-9604?

AOD-9604 is a synthetic peptide developed from a small section of the much larger human growth hormone molecule.

Human growth hormone contains 191 amino-acid residues.

AOD-9604 consists of a modified sequence associated with the C-terminal portion of hGH.

Its reported sequence is:

Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe

This can also be represented as:

YLRIVQCRSVEGSCGF

Because the compound contains 16 amino-acid residues, it is classified as a hexadecapeptide.

Is AOD-9604 the Same as HGH Fragment 176-191?

AOD-9604 is frequently associated with the term HGH Fragment 176-191, but researchers should pay attention to the exact molecular sequence being discussed.

FDA documentation describes AOD-9604 as a synthetic fragment containing hGH amino acids 177-191 plus an additional N-terminal tyrosine.

This produces a 16-amino-acid peptide.

Different publications and commercial sources sometimes use slightly different numbering conventions when describing the fragment.

For analytical research, the actual sequence and batch documentation should therefore be verified rather than relying only on the product nickname.

Why Was AOD-9604 Developed?

AOD-9604 emerged from research investigating whether particular regions of human growth hormone could be studied independently from the complete 191-amino-acid hormone.

Researchers were particularly interested in the C-terminal region and its possible involvement in lipid-related metabolic pathways.

This resulted in investigations of a modified peptide fragment rather than the complete growth hormone molecule.

The research hypothesis was that a smaller peptide might allow scientists to examine certain metabolic pathways separately from the broader biological actions associated with intact hGH.

AOD-9604 5mg Research Applications

AOD-9604 may be relevant to appropriately designed investigations involving:

Peptide characterization
Lipid-metabolism research
Adipocyte research
Lipolysis-related pathways
Lipogenesis-related pathways
Metabolic signaling
Peptide stability
Peptide degradation
Molecular characterization
Structure-activity research
Analytical chemistry
Peptide metabolism
Mass-spectrometry research
Experimental metabolic models

These are areas of scientific investigation rather than established therapeutic benefits.

AOD-9604 and Lipid-Metabolism Research

Much of the early scientific interest surrounding AOD-9604 involved lipid metabolism.

Researchers investigated whether the C-terminal region of growth hormone was associated with biological processes involving the storage and mobilization of lipids.

Experimental animal and cellular studies subsequently examined AOD-9604 and related hGH fragments in areas including:

Lipolysis
Lipogenesis
Fat oxidation
Adipocyte metabolism
Metabolic signaling

Much of this mechanistic evidence comes from preclinical research.

Researchers should therefore distinguish experimental findings in cellular or animal models from demonstrated clinical outcomes in humans.

AOD-9604 and Adipocyte Research

Adipocytes are specialized cells responsible primarily for storing energy in the form of lipids.

They provide an important experimental model for metabolic research.

AOD-9604 and related hGH fragments have been investigated in laboratory models examining how adipose cells regulate lipid storage and mobilization.

Such studies may help researchers examine biochemical pathways involved in adipocyte metabolism without requiring the use of full-length human growth hormone.

AOD-9604 vs Human Growth Hormone

AOD-9604 and full-length human growth hormone are fundamentally different research materials.

Human Growth Hormone

Human growth hormone is a protein consisting of 191 amino acids and has broad biological activity involving growth, metabolism, and endocrine signaling.

AOD-9604

AOD-9604 contains only 16 amino-acid residues and represents a modified fragment associated with the C-terminal region of hGH.

AOD-9604 should therefore not be described as equivalent to human growth hormone.

Its smaller structure and different biological characteristics create distinct experimental questions.

AOD-9604 and IGF-1 Research

One reason researchers became interested in C-terminal hGH fragments was the possibility of separating certain metabolic effects from the classical growth-related signaling associated with full-length growth hormone.

Preclinical research has investigated whether AOD-9604 produces the same type of growth hormone receptor and insulin-like growth factor 1 (IGF-1) signaling associated with intact hGH.

Published experimental findings have contributed to the hypothesis that the fragment behaves differently from full-length growth hormone.

However, these findings do not establish AOD-9604 as an approved or clinically effective treatment.

AOD-9604 and Peptide Metabolism Research

AOD-9604 is also relevant to analytical peptide research.

Scientists have developed laboratory methods to identify AOD-9604 and investigate how the peptide is metabolized.

Published analytical research has identified potential metabolites after incubation of AOD-9604 in serum and urine.

This makes the compound relevant to investigations involving:

Peptide degradation
Metabolite identification
Mass spectrometry
Analytical detection
Serum stability
Molecular characterization
Peptide metabolism

These applications illustrate how AOD-9604 research extends beyond metabolic pathway studies.

AOD-9604 Clinical Research

AOD-9604 progressed beyond preclinical investigation into human clinical development.

The compound was investigated as a potential obesity-related pharmaceutical candidate.

However, the development program did not establish AOD-9604 as an approved obesity treatment.

Available regulatory reviews have highlighted limitations in the evidence supporting effectiveness and have identified uncertainties surrounding safety, characterization, and potential immunogenicity associated with peptide products.

This distinction is particularly important when discussing commercially available research materials.

AOD-9604 5mg supplied for research should not be represented as an approved weight-loss medication.

Does AOD-9604 Cause Weight Loss?

It is not appropriate to describe a commercial AOD-9604 5mg Research Peptide as a proven weight-loss product.

Early preclinical experiments generated interest in AOD-9604 because of findings involving lipid metabolism and body composition in animal models.

However, preclinical findings do not automatically translate into clinical effectiveness.

The human development program did not result in FDA approval of AOD-9604 as a weight-loss drug.

For this reason, Axion Peptide Lab presents AOD-9604 strictly as a research-use-only peptide rather than as a weight-management treatment.

AOD-9604 5mg Research Peptide Features

The AOD-9604 5mg Research Peptide supplied by Axion Peptide Lab is intended exclusively for controlled research applications.

Key characteristics include:

5mg research format
Synthetic 16-amino-acid peptide
Modified C-terminal hGH fragment
Relevant to peptide characterization
Relevant to lipid-metabolism research
Suitable for adipocyte-related investigations
Suitable for peptide stability studies
Relevant to analytical chemistry
Suitable for peptide-metabolism research
Clearly labeled research-use-only presentation
Secure and discreet packaging
Batch documentation where available
USA-based supplier
Worldwide shipping options

Researchers should verify the specifications and documentation associated with the individual batch before beginning experimental work.

What Does AOD-9604 5mg Mean?

The 5mg designation identifies the nominal amount of AOD-9604 research material associated with the product.

It does not represent instructions for administration or a recommended human dose.

Laboratory quantity and clinical dosage are different concepts.

Experimental concentrations and procedures should be determined according to appropriately designed research protocols.

AOD-9604 vs Tirzepatide

AOD-9604 and tirzepatide are structurally and pharmacologically different compounds.

AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone.

Tirzepatide is a dual GIP/GLP-1 receptor agonist.

Although both have appeared within metabolic research, their structures, receptor pharmacology, evidence bases, and research applications are different.

Findings involving one compound should not be attributed to the other.

AOD-9604 vs Retatrutide

AOD-9604 is also different from retatrutide.

AOD-9604: Modified C-terminal hGH fragment.

Retatrutide: Investigational GIP/GLP-1/glucagon receptor agonist.

These compounds investigate substantially different biological pathways.

Researchers should select materials based on the specific mechanisms and objectives of their experiments.

Is AOD-9604 5mg Intended for Human Use?

No.

AOD-9604 5mg Research Peptide supplied by Axion Peptide Lab is intended strictly for laboratory, analytical, and scientific research.

It is not offered as a medicine, dietary supplement, or treatment and is not intended for human or veterinary consumption or administration.

The 5mg designation describes the nominal quantity of research material and does not constitute dosing guidance.

Where Can I Buy AOD-9604 5mg for Research?

Researchers looking to buy AOD-9604 5mg Research Peptide can explore current availability through Axion Peptide Lab.

Axion Peptide Lab is a USA-based supplier of research-use-only peptides, compounds, blends, and laboratory materials.

Our products are intended for controlled laboratory, analytical, and scientific applications.

Website: AxionPeptideLab.com

Email: order@axionpeptidelab.com

Based in: United States

Shipping: USA & eligible worldwide destinations

Buy Research Peptides in the USA

Axion Peptide Lab provides multiple research materials for appropriately designed scientific investigations.

Our catalog includes:

AOD-9604 5mg Research Peptide

Modified C-terminal human growth hormone fragment intended for controlled laboratory and analytical research.